Josephine Namusanje
Overview
Explore the profile of Josephine Namusanje including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
3
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Nicolo A, Palermiti A, Mugerwa H, Nakabuye S, Namusanje J, Kobusingye J, et al.
Clin Pharmacol Ther
. 2025 Feb;
PMID: 39891354
Ritonavir-boosted atazanavir is a victim of drug-drug interaction with rifampicin, a key component of antitubercular treatment. In a recent dose escalation clinical trial, we showed that increasing atazanavir/ritonavir to 300/100 ...
2.
Riitho V, Connon R, Gwela A, Namusanje J, Nhema R, Siika A, et al.
Nat Commun
. 2024 Jun;
15(1):5492.
PMID: 38944653
One-third of people with HIV in sub-Saharan Africa start antiretroviral therapy (ART) with advanced disease. We investigated associations between immune biomarkers and mortality in participants with advanced HIV randomised to...
3.
Barlow-Mosha L, Ahimbisibwe G, Chappell E, Amuge P, Nanduudu A, Kaudha E, et al.
J Int AIDS Soc
. 2023 Sep;
26(9):e26174.
PMID: 37766505
Introduction: Dolutegravir-based antiretroviral therapy (ART) is the preferred antiretroviral treatment for children and adolescents living with HIV. A large surveillance study in Botswana previously raised concerns about an association between...